Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis

This double-blind, placebo-controlled study evaluated the safety and efficacy of intravenous (i.v.) calcitriol (Calcijex) for treatment of secondary hyperparathyroidism (secondary HPT) in pediatric end-stage renal disease (ESRD) patients on hemodialysis (HD). After a 2 to 6-week washout period of al...

Full description

Saved in:

Bibliographic Details
Published in:	Pediatric nephrology (Berlin, West) Vol. 20; no. 5; pp. 622 - 630
Main Authors:	Greenbaum, Larry A, Grenda, Ryszard, Qiu, Ping, Restaino, Irene, Wojtak, Amy, Paredes, Ana, Benador, Nadine, Melnick, Joel Z, Williams, Laura A, Salusky, Isidro B
Format:	Journal Article
Language:	English
Published:	Germany Springer 01-05-2005 Springer Nature B.V
Subjects:	Acetates - administration & dosage Adolescent Calcitriol Calcitriol - administration & dosage Calcitriol - adverse effects Calcium - blood Calcium Carbonate - administration & dosage Calcium Channel Agonists - administration & dosage Calcium Channel Agonists - adverse effects Calcium Compounds Child Child, Preschool Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy Chronic Kidney Disease-Mineral and Bone Disorder - etiology Diseases Dosage and administration Drug therapy Female Hemodialysis patients Humans Hyperparathyroidism Hyperparathyroidism, Secondary - drug therapy Hyperparathyroidism, Secondary - etiology Injections, Intravenous Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Parathyroid Hormone - blood Phosphates - blood Renal Dialysis United States
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!